Breaking News

Tweet TWEET

GLAXO: DRISAPERSEN TO GET FDA BREAKTHROUGH THERAPY DESIGNATION

     (The following press release from GlaxoSmithKline was received by e-mail. 
It was not confirmed by the sender.)